ADC Therapeutics
Tara Forth is a seasoned professional in the field of medical science and oncology, currently serving as a Senior Medical Science Liaison at ADC Therapeutics since November 2022. Prior experience includes roles as Senior Medical Science Liaison and Hematology/Oncology Specialist at Karyopharm Therapeutics Inc., where Tara contributed to the launch of innovative therapies in the Hematology/Oncology community. Previous positions involve Clinical Oncology Specialist in Immunotherapy at Genentech, a Casual Clinical Research Nurse at West Virginia University School of Nursing, and various roles in sales and clinical consulting within the pharmaceutical industry, including experience with Bristol-Myers Squibb and sanofi-aventis. Tara holds a BS in Nursing from West Virginia University and a BA in Counseling and Rehabilitation from Marshall University.
This person is not in any offices
ADC Therapeutics
2 followers
ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.